Skip to main content
Premium Trial:

Request an Annual Quote

Frank Witney

Gyros Protein Technologies has appointed Frank Witney as a chairman of the board. Witney succeeds David Patterson, who remains at the company as a director. Most recently, Witney served as president and CEO of Affymetrix, which was acquired by Thermo Fisher Scientific in March 2016. He also served as president and CEO of Dionex, which was also acquired by Thermo Fisher Scientific, and has held executive roles at various companies — he was president and CEO of Panomics, which was acquired by Affymetrix, and chief operating officer of Packard Biosciences, which was acquired by PerkinElmer.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.